update CRM Inc. Company Profile

03:40 EST 19th November 2017 | BioPortfolio

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the US. update CRM’s parent company, update software AG, is the leading developer of CRM products in Europe and boasts more than twenty years of CRM experience and more than 160,000 end users in more than 1,400 customers worldwide. Update software has subsidiaries in the US, Germany, Switzerland, the Netherlands, France, Hungary, the Czech Republic, and Poland, and is listed on the German stock exchange in Frankfurt am Main.

News Articles [183 Associated News Articles listed on BioPortfolio]

Update: French Red Blood Cell Biotech Enters Nasdaq with a $144M IPO

Update (15/11/2017): Erytech has closed its Nasdaq IPO raising a total of $144M (€122M) despite setting an initial goal of $100M. Way to go!  Update (10/11/2017): Erytech has upgraded its projected...

Novartis receives approval in the EU for Cosentyx label update

Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Cosentyx® (secukinumab), the first interleukin-17A (IL-17A) approved to treat pso...

Researchers publish 2017 update of SpA, PsA treatments to target

Researchers have published a 2017 update of treatments to target for patients with axial spondyloarthritis, peripheral spondyloarthritis and psoriatic arthritis.“[An] update of recommendations to tr...

Actelion spin-out Idorsia provides pipeline update

Switzerland-based Idorsia today announced its financial results and an update on its research progress,…

Update: FDA Clears the Way to Approval for Novartis’ Key Competitor in CAR-T Race

UPDATE 08/08/2017: The FDA has cleared Kite to skip the outside advisors hearing in the approval process, signaling that Novartis’ main competitor may launch its CAR-T  therapy as early as Sept...

Update: Clinical Holds Lifted for First Off-the-Shelf CAR-T Therapy

UPDATE: The FDA has lifted both clinical holds provided that Cellectis decreases the dose of both UCART123 and the lymphodepletion regimen, the next three patients will be under the age of 65, and tha...

Siemens to issue security update for some PET scanners this month

A spokesman for Siemens said Monday that the company will release a software update for Microsoft Windows 7-based versions of -More- 

Bioventix Plc - Trading Update, Notice of Results & AGM

PR NewswireLondon, September 1 Bioventix plc ("Bioventix" or the "Company") Trading Update, Notice of Results and AGM Trading Update Bioventix plc (BVXP), a UK company specialising in the developm...

Drugs and Medications [0 Results]


PubMed Articles [472 Associated PubMed Articles listed on BioPortfolio]

Update on tauopathies.

The purpose of this review is to provide an update on the role of tau beyond the stabilization of microtubules and on the clinical, pathological, diagnostic and therapeutic aspects of tauopathies.

Noonan syndrome: an update on growth and development.

To provide an update on recent developments on Noonan syndrome with a special focus on endocrinology, bone, and metabolism aspects. The key issues still to be resolved and the future therapeutic persp...

Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project.

As part of the World Cancer Research Fund International Continuous Update Project, we updated the systematic review and meta-analysis of prospective studies to quantify the dose-response between foods...

Clinical Update: Osteoporosis Management.

The clinical update serves as a brief review of recently published, high-impact, and potentially practice changing journal articles summarized for our readers. Topics include menopause, sexual dysfunc...

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.

Non-classic congenital hyperplasia (NCAH) due to 21-hydroxylase deficiency is a common autosomal recessive disorder characterized by androgen excess.

Clinical Trials [67 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Support Annual Strain Update, Safey and Immnogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

This phase II, open label, is designed as a seasonal study to support annual strain update evaluating the safety, clinical tolerability and immunogenicity of the 2007-2008 formulation of ...

Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and Diet

This study was an update and amplification of exposure measurements of the EPIC-Potsdam Study, which started in 1994-1998.

A Prospective Double-Blind Study of Retrovir in Early HIV Infection

To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) to adult patients with early manifestations of HIV disease. To assess the efficacy of AZT therapy in the tr...

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

This Phase 4, prospective, multicenter, non-interventional, regulatory post-marketing surveillance study will collect information on the the safety and effectiveness of atezolizumab under ...

Companies [46 Associated Companies listed on BioPortfolio]

update CRM Inc.

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the U...

Update AG


Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the...

The Hartford Income Shares Fund, Inc.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or b...


WHAT:2012 Annual Meeting featuring Gov. Robert Bentley, an update of the BioAlabama Five Year Strategic Plan and presentation of Biotechnology Resolution by Sen. Jabo Waggoner and...

More Information about "update CRM Inc." on BioPortfolio

We have published hundreds of update CRM Inc. news stories on BioPortfolio along with dozens of update CRM Inc. Clinical Trials and PubMed Articles about update CRM Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of update CRM Inc. Companies in our database. You can also find out about relevant update CRM Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record